(R)-N-(1-(5-(Trifluoromethyl)pyridin-2-yl)ethyl)cyclopropanamine, 5g

3,5-Difluoro-2-methoxypyridine, 95%, 250mg

2-BROMO-4-IODOBENZONITRILE, 95%, 25g

((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol, 95.0%, 1g

(5-Bromo-2-methylphenyl)methanamine hydrochloride, 100mg

Methyl trans-4-Aminocyclohexanecarboxylate Hydrochloride>98.0%(N)(T)5g

1-METHYL-5-NITRO-1H-PYRROLE-2-CARBOXYLIC ACID, 95.0%, 1g

tert-Butyl 8-(hydroxymethyl)-2-azaspiro[4.5]decane-2-carboxylate, 97%, 250mg

ROTI®Pol Hot-TaqS, 200 µl, 5 x 40 µl

(2,4,5-Trifluorophenyl)acetic acid methyl ester, 98.0%, 5g

ethyl 6-bromo-4-hydroxy-1,8-naphthyridine-3-carboxylate, 99.22%, 250mg

2-(S-Methylsulfonimidoyl)ethanol, 97%, 250mg

(S)-1-(4-Bromophenyl)-2-methoxyethanamine, 98%, 250mg